GADD45α inhibitors belong to a specific chemical class of compounds meticulously designed to modulate the activity of the GADD45α protein. GADD45α, or growth arrest and DNA damage-inducible protein 45 alpha, is a protein that is induced in response to various cellular stressors, including DNA damage, oxidative stress, and certain growth factors. These inhibitors are thoughtfully crafted molecules engineered to interact with the GADD45α protein, influencing its normal function. Through these interactions, they might impact various cellular processes associated with cell cycle regulation, DNA repair, and cellular responses, without directly altering its binding sites or its involvement in stress-induced signaling pathways.
The design of GADD45α inhibitors is grounded in a comprehensive understanding of the structural and functional attributes of the GADD45α protein. Typically developed using advanced chemical synthesis methods and informed by insights from cell biology and stress response mechanisms, these inhibitors are characterized by their ability to selectively bind to GADD45α. This selectivity enables focused modulation of cellular pathways that rely on the activity of this specific protein. Unraveling the intricacies of stress response, DNA repair mechanisms, and cellular adaptation often employ GADD45α inhibitors as valuable tools. The development and utilization of GADD45α inhibitors contribute to advancing our knowledge of the complex interplay between cellular components and stress-induced dynamics, offering insights into the fundamental molecular mechanisms that govern cellular responses to various stressors and contribute to cellular adaptations to environmental challenges.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, downstream of GADD45α, involved in stress responses and inflammation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Blocks JNK pathway, inhibiting GADD45α induction and stress-related signaling. | ||||||
UCN-01 | 112953-11-4 | sc-202376 | 500 µg | $251.00 | 10 | |
Protein kinase C inhibitor, prevents GADD45α induction through modulation of cell cycle and DNA damage pathways. | ||||||
9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine | 1380288-87-8 | sc-500607 | 50 mg | $13500.00 | ||
Inhibits DOT1L histone methyltransferase, impacting GADD45α gene expression in certain leukemia types. | ||||||
2′-Deoxyadenosine monohydrate | 16373-93-6 | sc-216290 sc-216290A | 250 mg 1 g | $32.00 $47.00 | 2 | |
Acts as a GADD45α inhibitor by affecting DNA repair pathways and inducing cell cycle arrest. | ||||||
Deoxyschizandrin | 61281-38-7 | sc-278925 | 10 mg | $80.00 | ||
Modulates MAPK signaling pathways and suppresses GADD45α expression involved in oxidative stress response. | ||||||